Moreover, as a low level of high-density lipoprotein (HDL) is an independent risk factor for pathological cardiac hypertrophy, downregulation of AT1R and HDL was shown to ameliorate cardiac hypertrophy via P13K/Akt-dependent mechanism [89]. The gene discussed is AKT1; the disease is cardiac hypertrophy.